Retatrutide

Retatrutide is stocked in 10mg and 20mg lyophilised vials. Current pricing is shown in the buy box above, and quantity breaks reduce the per-vial cost from two vials upward. Each size is its own batch with its own published Certificate of Analysis.

This batch of Retatrutide assays at 99.66% by HPLC. Every batch is independently tested by a third-party laboratory using HPLC for purity and mass spectrometry for identity, and the Certificate of Analysis for the batch is published — you can read the actual report rather than take a number on a product page at face value.

Store the unreconstituted lyophilised powder sealed at -20°C, protected from light and moisture, and allow vials to reach room temperature before opening so condensation does not form on the hygroscopic cake. Once reconstituted, keep the solution cold and protected from light, and prepare single-use aliquots rather than freeze–thaw cycling a stock vial repeatedly.

Add bacteriostatic or sterile water gently down the inside wall of the vial and swirl until the cake dissolves — do not shake, which foams the solution and can denature peptide at the air–liquid interface. The resulting concentration is the vial mass divided by the volume added. Our reconstitution calculator does that arithmetic for any vial size and target concentration.

Yes. Retatrutide (20mg) is held in Australian stock and dispatched from our Australian facility, so there are no international customs delays. Orders placed before 12pm AEST on a business day are dispatched the same day by tracked express post, generally arriving within 1–4 business days. Free express shipping applies on orders over $300.

No. Retatrutide is supplied for in-vitro laboratory research use only and is not for human or veterinary use, consumption, or therapeutic application. It is not a therapeutic good, and no statement on this site has been evaluated by the Therapeutic Goods Administration. Purchase is limited to qualified researchers and laboratories over 18.